| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.14 | 0.3 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |